CRYOPORT, INC. Peo Actually Paid Comp Amt
CRYOPORT, INC. (CYRX) reported Peo Actually Paid Comp Amt of $2.65 million for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-22.
Financial Statements › Cash Flow › Other Cash Flow Items
ecd:PeoActuallyPaidCompAmt · last filed 2026-04-22
| Period end | Peo Actually Paid Comp Amt 12 month |
|---|---|
| 2025-12-31 | $2.65M DEF 14A · filed 2026-04-22 |
| 2024-12-31 | $962.52K DEF 14A · filed 2026-04-22 |
| 2023-12-31 | $1.50M DEF 14A · filed 2026-04-22 |
| 2022-12-31 | -$7.38M DEF 14A · filed 2026-04-22 |
| 2021-12-31 | $9.64M DEF 14A · filed 2026-04-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |